Kim Henriksen

High-performance cluster-based Internet servers

Eric Jul, Michael Svendsen, Jørgen S. Hansen, 2000, OPSR.

Effects of ovariectomy and estrogen therapy on type II collagen degradation and structural integrity of articular cartilage in rats: implications of the time of initiation.

Claus Christiansen, Kim Henriksen, M. Karsdal, 2006, Arthritis and rheumatism.

Cartilage degradation is fully reversible in the presence of aggrecanase but not matrix metalloproteinase activity

Claus Christiansen, Kim Henriksen, M. Karsdal, 2008, Arthritis research & therapy.

Dissociation of Bone Resorption and Bone Formation in Adult Mice with a Non-Functional V-ATPase in Osteoclasts Leads to Increased Bone Strength

Johan Richter, Vincent Everts, Kim Henriksen, 2011, PloS one.

Transforming Growth Factor-β Controls Human Osteoclastogenesis through the p38 MAPK and Regulation of RANK Expression*

Kim Henriksen, M. Karsdal, J. Delaissé, 2003, Journal of Biological Chemistry.

The future of blood-based biomarkers for Alzheimer's disease

Michael W. Weiner, Harald Hampel, John Q. Trojanowski, 2014, Alzheimer's & Dementia.

Extracellular matrix remodeling: the common denominator in connective tissue diseases. Possibilities for evaluation and current understanding of the matrix as more than a passive architecture, but a key player in tissue failure.

Claus Christiansen, Kim Henriksen, M. Karsdal, 2013, Assay and drug development technologies.

Serological biochemical markers of surrogate efficacy and safety as a novel approach to drug repositioning.

Claus Christiansen, Kim Henriksen, M. Karsdal, 2011, Drug discovery today.

Efficacy and safety of the PPARγ partial agonist balaglitazone compared with pioglitazone and placebo: a phase III, randomized, parallel‐group study in patients with type 2 diabetes on stable insulin therapy

Claus Christiansen, Hans Perrild, Inger Byrjalsen, 2011, Diabetes/metabolism research and reviews.

Which elements are involved in reversible and irreversible cartilage degradation in osteoarthritis?

Kim Henriksen, M. Karsdal, E. Dam, 2010, Rheumatology International.

Developing novel blood-based biomarkers for Alzheimer's disease

Sid O'Bryant, Tim West, Simon Lovestone, 2014, Alzheimer's & Dementia.

Assessment of osteoclast number and function: application in the development of new and improved treatment modalities for bone diseases

Claus Christiansen, László B. Tankó, Kim Henriksen, 2007, Osteoporosis International.

Are Nonresorbing Osteoclasts Sources of Bone Anabolic Activity?

Claus Christiansen, Jens Bollerslev, Kim Henriksen, 2007, Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research.